Abstract:Interferon-inducible transmembrane (IFITM) proteins are small homologous proteins that are encoded by the interferon-stimulated genes (ISGs), which can be strongly induced by interferon (IFN) and provide resistance to invasion by a variety of viral pathogens. However, the exact molecular mechanisms underlying this function have remained elusive. The antiviral activity of IFITMs from different species depends on S-palmitoylation at conserved cysteine residues. However, specific enzymes involved in the dynamic palmitoylation cycle of IFITMs, especially depalmitoylase, have not yet been reported. Here, we demonstrate that α/-hydrolase domain-containing 16A (ABHD16A) is a depalmitoylase and a negative regulator of IFITM protein that can catalyze the depalmitoyl reaction of S-palmitoylated IFITM proteins, thereby decreasing their antiviral activities on RNA viruses. Using the acyl-PEGyl exchange gel shift (APEGS) assay, we identified ABHD16A proteins from humans, pigs, and mice that can directly participate in the palmitoylation/depalmitoylation cycles of IFITMs in the constructed abhd16a-/- cells and ABHD16A-overexpressing cells. Furthermore, we showed that ABHD16A functions as a regulator of subcellular localization of IFITM proteins and is related to the immune system. It is tempting to suggest that pharmacological intervention in IFITMs and ABHD16A can be achieved either through controlling their expression or regulating their activity, thereby providing a broad-spectrum therapeutic strategy for animal viral diseases. IMPORTANCE IFITM protein is the cells first line of antiviral defense that blocks early stages of viral replication; the underlying mechanism might be associated with the proper distribution in cells. The palmitoylation/depalmitoylation cycle can dynamically regulate protein localization, stability, and function. This work is the first one that found the critical enzyme that participates in the palmitoylation/depalmitoylation cycle of IFITM, and this type of palmitoyl loss may be an essential regulation mode for balancing the antiviral functions of the IFN pathway. These findings imply that the pharmacological intervention in IFITM and ABHD16A, either through controlling their expression or regulating their activities, could provide a broad-spectrum therapeutic strategy for animal viral diseases and complications linked to interferon elevation.

PADI4 negatively regulates RIG-I-mediated antiviral response through deacetylation of IFN-β promoter via HDAC1

NBR1 Mediates Autophagic Degradation of IRF3 to Negatively Regulate Type I Interferon Production.

Gcn5 and PCAF Negatively Regulate Interferon‐β Production Through HAT‐independent Inhibition of TBK1

Single-nucleotide methylation specifically represses type I interferon in antiviral innate immunity

Host HDAC4 Regulates the Antiviral Response by Inhibiting the Phosphorylation of IRF3

Phosphatase Pp4 Negatively Regulates Type I Ifn Production and Antiviral Innate Immunity by Dephosphorylating and Deactivating Tbk1

Role of Citrullination Modification Catalyzed by Peptidylarginine Deiminase 4 in Gene Transcriptional Regulation

Degradation of HDAC10 by autophagy promotes IRF3-mediated antiviral innate immune responses

Downregulated NDR1 Protein Kinase Inhibits Innate Immune Response by Initiating an Mir146a-Stat1 Feedback Loop

DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response

PIAS1 Negatively Modulates Virus Triggered Type I IFN Signaling by Blocking the DNA Binding Activity of IRF3

DDX4 enhances antiviral activity of type I interferon by disrupting interaction of USP7/SOCS1 and promoting degradation of SOCS1

Cytoplasmic Stat4 Promotes Antiviral Type I Ifn Production by Blocking Chip-Mediated Degradation of Rig-I

ABHD16A Negatively Regulates the Palmitoylation and Antiviral Function of IFITM Proteins

NLRP4 Negatively Regulates Type I Interferon Signaling by Targeting the Kinase TBK1 for Degradation Via the Ubiquitin Ligase DTX4

IL-4 Inhibits the Biogenesis of an Epigenetically Suppressive PIWI-Interacting RNA To Upregulate CD1a Molecules on Monocytes/Dendritic Cells.

Negative Regulation of NIP45 Function by Peptidylarginine Deminase 4 (87.28)

Inhibition of Histone Deacetylase Activity Suppresses IFN-γ Induction of Tripartite Motif 22 Via CHIP-mediated Proteasomal Degradation of IRF-1.

PADI4 Epigenetically Suppresses P21 Transcription and Inhibits Cell Apoptosis in Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients.

A Long Non-coding RNA IVRPIE Promotes Host Antiviral Immune Responses Through Regulating Interferon β1 and ISG Expression

PZR suppresses innate immune response to RNA viral infection by inhibiting MAVS activation in interferon signaling mediated by RIG-I and MDA5